Bausch + Lomb extends drop as Wells Fargo downgrades on enVista recall
Bausch + Lomb (NYSE:BLCO) continued to trade lower on Friday as Wells Fargo downgraded the Canadian eyecare firm in reaction ...
Yahoo Finance6d
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty
Bausch + Lomb announced a recall of its enVista IOLs, including Aspire, Envy, and certain lots of monofocal lenses, due to reports of toxic anterior segment syndrome. Wells Fargo highlighted that ...
Bausch + Lomb downgraded to Equal Weight from Overweight at Wells Fargo
Wells Fargo downgraded Bausch + Lomb (BLCO) to Equal Weight from Overweight with a price target of $15, down from $24.Light Up your Portfolio ...
Bausch + Lomb cut to Equal Weight at Wells Fargo following enVista recall
Wells Fargo downgraded Bausch + Lomb (BLCO) to Equal Weight from Overweight with a price target of $15, down from $24. The company’s announced ...
Bausch + Lomb (NYSE:BLCO) Reaches New 52-Week Low on Analyst Downgrade
Bausch + Lomb Co. (NYSE:BLCO – Get Free Report)’s stock price reached a new 52-week low during trading on Thursday after ...
Bausch + Lomb (NYSE:BLCO) Receives Equal Weight Rating from Wells Fargo & Company
Wells Fargo & Company reiterated their equal weight rating on shares of Bausch + Lomb (NYSE:BLCO – Free Report) in a report issued on Friday morning, MarketBeat.com reports. They currently have a $15.
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty
Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to weigh on sales growth, ...
Seeking Alpha6d
Bausch + Lomb extends drop as Wells Fargo downgrades on enVista recall
Bausch + Lomb (NYSE:BLCO) continued to trade lower on Friday as Wells Fargo downgraded the Canadian eyecare firm in reaction to a voluntary recall of several brands of its enVista line of ...